Cargando…
Microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the GlycoScore III study
BACKGROUND: Vascular abnormalities and endothelial dysfunction are part of the spectrum of autosomal dominant polycystic kidney disease (ADPKD). The mechanisms behind these manifestations, including potential effects on the endothelial surface layer (ESL) and glycocalyx integrity, remain unknown. ME...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900573/ https://www.ncbi.nlm.nih.gov/pubmed/36755834 http://dx.doi.org/10.1093/ckj/sfac229 |
_version_ | 1784882877146595328 |
---|---|
author | Fuchs, Alexander Dederichs, Jennifer Arjune, Sita Todorova, Polina Wöstmann, Fabian Antczak, Philipp Illerhaus, Anja Gathof, Birgit Grundmann, Franziska Müller, Roman-Ulrich Annecke, Thorsten |
author_facet | Fuchs, Alexander Dederichs, Jennifer Arjune, Sita Todorova, Polina Wöstmann, Fabian Antczak, Philipp Illerhaus, Anja Gathof, Birgit Grundmann, Franziska Müller, Roman-Ulrich Annecke, Thorsten |
author_sort | Fuchs, Alexander |
collection | PubMed |
description | BACKGROUND: Vascular abnormalities and endothelial dysfunction are part of the spectrum of autosomal dominant polycystic kidney disease (ADPKD). The mechanisms behind these manifestations, including potential effects on the endothelial surface layer (ESL) and glycocalyx integrity, remain unknown. METHODS: Forty-five ambulatory adult patients with ADPKD were enrolled in this prospective, observational, cross-sectional, single-centre study. Fifty-one healthy volunteers served as a control group. All participants underwent real-time microvascular perfusion measurements of the sublingual microcirculation using sidestream dark field imaging. After image acquisition, the perfused boundary region (PBR), an inverse parameter for red blood cell (RBC) penetration into the ESL, was automatically calculated. Microvascular perfusion was assessed by RBC filling and capillary density. Concentrations of circulating glycocalyx components were determined by enzyme-linked immunosorbent assay. RESULTS: ADPKD patients showed a significantly larger PBR compared with healthy controls (2.09 ± 0.23 µm versus 1.79 ± 0.25 µm; P < .001). This was accompanied by significantly lower RBC filling (70.4 ± 5.0% versus 77.9 ± 5.4%; P < .001) as well as a higher valid capillary density {318/mm(2) [interquartile range (IQR) 269–380] versus 273/mm(2) [230–327]; P = .007}. Significantly higher plasma concentrations of heparan sulphate (1625 ± 807 ng/ml versus 1329 ± 316 ng/ml; P = .034), hyaluronan (111 ng/ml [IQR 79–132] versus 92 ng/ml [82–98]; P = .042) and syndecan-1 were noted in ADPKD patients compared with healthy controls (35 ng/ml [IQR 27–57] versus 29 ng/ml [23–42]; P = .035). CONCLUSIONS: Dimensions and integrity of the ESL are impaired in ADPKD patients. Increased capillary density may be a compensatory mechanism for vascular dysfunction to ensure sufficient tissue perfusion and oxygenation. |
format | Online Article Text |
id | pubmed-9900573 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-99005732023-02-07 Microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the GlycoScore III study Fuchs, Alexander Dederichs, Jennifer Arjune, Sita Todorova, Polina Wöstmann, Fabian Antczak, Philipp Illerhaus, Anja Gathof, Birgit Grundmann, Franziska Müller, Roman-Ulrich Annecke, Thorsten Clin Kidney J Original Article BACKGROUND: Vascular abnormalities and endothelial dysfunction are part of the spectrum of autosomal dominant polycystic kidney disease (ADPKD). The mechanisms behind these manifestations, including potential effects on the endothelial surface layer (ESL) and glycocalyx integrity, remain unknown. METHODS: Forty-five ambulatory adult patients with ADPKD were enrolled in this prospective, observational, cross-sectional, single-centre study. Fifty-one healthy volunteers served as a control group. All participants underwent real-time microvascular perfusion measurements of the sublingual microcirculation using sidestream dark field imaging. After image acquisition, the perfused boundary region (PBR), an inverse parameter for red blood cell (RBC) penetration into the ESL, was automatically calculated. Microvascular perfusion was assessed by RBC filling and capillary density. Concentrations of circulating glycocalyx components were determined by enzyme-linked immunosorbent assay. RESULTS: ADPKD patients showed a significantly larger PBR compared with healthy controls (2.09 ± 0.23 µm versus 1.79 ± 0.25 µm; P < .001). This was accompanied by significantly lower RBC filling (70.4 ± 5.0% versus 77.9 ± 5.4%; P < .001) as well as a higher valid capillary density {318/mm(2) [interquartile range (IQR) 269–380] versus 273/mm(2) [230–327]; P = .007}. Significantly higher plasma concentrations of heparan sulphate (1625 ± 807 ng/ml versus 1329 ± 316 ng/ml; P = .034), hyaluronan (111 ng/ml [IQR 79–132] versus 92 ng/ml [82–98]; P = .042) and syndecan-1 were noted in ADPKD patients compared with healthy controls (35 ng/ml [IQR 27–57] versus 29 ng/ml [23–42]; P = .035). CONCLUSIONS: Dimensions and integrity of the ESL are impaired in ADPKD patients. Increased capillary density may be a compensatory mechanism for vascular dysfunction to ensure sufficient tissue perfusion and oxygenation. Oxford University Press 2022-10-19 /pmc/articles/PMC9900573/ /pubmed/36755834 http://dx.doi.org/10.1093/ckj/sfac229 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the ERA. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Original Article Fuchs, Alexander Dederichs, Jennifer Arjune, Sita Todorova, Polina Wöstmann, Fabian Antczak, Philipp Illerhaus, Anja Gathof, Birgit Grundmann, Franziska Müller, Roman-Ulrich Annecke, Thorsten Microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the GlycoScore III study |
title | Microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the GlycoScore III study |
title_full | Microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the GlycoScore III study |
title_fullStr | Microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the GlycoScore III study |
title_full_unstemmed | Microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the GlycoScore III study |
title_short | Microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the GlycoScore III study |
title_sort | microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the glycoscore iii study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900573/ https://www.ncbi.nlm.nih.gov/pubmed/36755834 http://dx.doi.org/10.1093/ckj/sfac229 |
work_keys_str_mv | AT fuchsalexander microvascularperfusionperfusedboundaryregionandglycocalyxsheddinginpatientswithautosomaldominantpolycystickidneydiseaseresultsfromtheglycoscoreiiistudy AT dederichsjennifer microvascularperfusionperfusedboundaryregionandglycocalyxsheddinginpatientswithautosomaldominantpolycystickidneydiseaseresultsfromtheglycoscoreiiistudy AT arjunesita microvascularperfusionperfusedboundaryregionandglycocalyxsheddinginpatientswithautosomaldominantpolycystickidneydiseaseresultsfromtheglycoscoreiiistudy AT todorovapolina microvascularperfusionperfusedboundaryregionandglycocalyxsheddinginpatientswithautosomaldominantpolycystickidneydiseaseresultsfromtheglycoscoreiiistudy AT wostmannfabian microvascularperfusionperfusedboundaryregionandglycocalyxsheddinginpatientswithautosomaldominantpolycystickidneydiseaseresultsfromtheglycoscoreiiistudy AT antczakphilipp microvascularperfusionperfusedboundaryregionandglycocalyxsheddinginpatientswithautosomaldominantpolycystickidneydiseaseresultsfromtheglycoscoreiiistudy AT illerhausanja microvascularperfusionperfusedboundaryregionandglycocalyxsheddinginpatientswithautosomaldominantpolycystickidneydiseaseresultsfromtheglycoscoreiiistudy AT gathofbirgit microvascularperfusionperfusedboundaryregionandglycocalyxsheddinginpatientswithautosomaldominantpolycystickidneydiseaseresultsfromtheglycoscoreiiistudy AT grundmannfranziska microvascularperfusionperfusedboundaryregionandglycocalyxsheddinginpatientswithautosomaldominantpolycystickidneydiseaseresultsfromtheglycoscoreiiistudy AT mullerromanulrich microvascularperfusionperfusedboundaryregionandglycocalyxsheddinginpatientswithautosomaldominantpolycystickidneydiseaseresultsfromtheglycoscoreiiistudy AT anneckethorsten microvascularperfusionperfusedboundaryregionandglycocalyxsheddinginpatientswithautosomaldominantpolycystickidneydiseaseresultsfromtheglycoscoreiiistudy |